NCT06037707 (COVID-19TC) is a clinical trial in COVID-19-Associated Thromboembolism, sponsored by Ayse Zeynep Turan.

Who is sponsoring NCT06037707?

NCT06037707 is sponsored by Ayse Zeynep Turan.

What condition does NCT06037707 study?

NCT06037707 studies COVID-19-Associated Thromboembolism.

Is NCT06037707 still recruiting?

NCT06037707 is currently completed. Last updated 25 January 2024.

Last reviewed 2024-01-25 · How we verify

NCT06037707: COVID-19TC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Thromboembolic Complications in COVID-19 Patients in Intensive Care Unit

Completed Last updated 25 January 2024

What this trial tests

trial in COVID-19-Associated Thromboembolism in 484 participants. Completed in 30 August 2023.

Timeline

1 January 2022

Primary endpoint
30 June 2022

30 August 2023

Quick facts

Lead sponsor	Ayse Zeynep Turan
Status	Completed
Study type	OBSERVATIONAL
Enrollment	484
Start date	1 January 2022
Primary completion	30 June 2022
Estimated completion	30 August 2023
Sites	1 location across Turkey (Türkiye)

Conditions studied

COVID-19-Associated Thromboembolism — all drugs for COVID-19-Associated Thromboembolism →

Sponsor

Ayse Zeynep Turan

Who can join

18 and older, any sex, with COVID-19-Associated Thromboembolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study aims to determine frequency of thromboembolic complications and the underlying causes of this complication of the patients who admitted to the intensive care unit diagnosed with COVID-19.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06037707 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ayse Zeynep Turan
Last refreshed: 25 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06037707.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing